OpenAI is reportedly in discussions with the U.S. Food and Drug Administration (FDA) about using AI to help evaluate pharmaceuticals, according to a new report from Wired.<br /> The article OpenAI plans "cderGPT" for the US Food and Drug Administration (FDA) appeared first on THE DECODER. [...]